Ballard Sarah-Blythe, Reaves Erik J, Luna C Giannina, Silva Maria E, Rocha Claudio, Heitzinger Kristen, Saito Mayuko, Apaza Sonia, Espetia Susan, Blazes David L, Tilley Drake H, Guzmán Aguilar Rene C, Gilman Robert H, Bausch Daniel G
Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America; Emerging Infectious Diseases Department, United States Medical Research Unit No. 6, Lima, Peru.
Emerging Infectious Diseases Department, United States Medical Research Unit No. 6, Lima, Peru.
PLoS One. 2015 Jul 10;10(7):e0131646. doi: 10.1371/journal.pone.0131646. eCollection 2015.
Successful vaccination strategies against norovirus will require understanding the burden of disease and relevant genotypes in populations. However, few data are available from cohort studies of adults living in low- and middle-income countries (LMIC).
We conducted a nested case-control study within a Peruvian military cohort to characterize the burden of norovirus infection, predominant genotypes, and associated symptoms from 2004 through 2011. Randomly selected case and control stools were tested for norovirus, bacteria, and parasites. The odds ratio of the association between norovirus infection and diarrhea was estimated using multiple logistic regression and co-infection adjusted attributable fractions were calculated.
Of the 3,818 cohort study participants, 624 developed diarrhea. Overall and norovirus-associated diarrhea incidence rates were 42.3 and 6.0 per 100 person-years, respectively. The most prevalent norovirus genogroup was GII (72.5%, 29/40), which was associated with diarrhea (AOR 3.4, 95% CI: 1.3-8.7, P = 0.012). The co-infection adjusted GII attributable fraction was 6.4%.
Norovirus was a frequent cause of diarrhea in an adult population followed longitudinally in an LMIC setting. Vaccine strategies should consider targeting adults in endemic settings and special populations that could serve as community transmission sources.
成功的诺如病毒疫苗接种策略需要了解人群中的疾病负担和相关基因型。然而,来自低收入和中等收入国家(LMIC)成年人群队列研究的数据很少。
我们在秘鲁一个军事队列中进行了一项巢式病例对照研究,以描述2004年至2011年期间诺如病毒感染的负担、主要基因型及相关症状。对随机选取的病例和对照的粪便进行诺如病毒、细菌和寄生虫检测。使用多因素逻辑回归估计诺如病毒感染与腹泻之间关联的比值比,并计算合并感染调整后的归因分数。
在3818名队列研究参与者中,624人出现腹泻。总体腹泻发病率和诺如病毒相关腹泻发病率分别为每100人年42.3例和6.0例。最常见的诺如病毒基因组是GII(72.5%,29/40),它与腹泻相关(调整后的比值比3.4,95%可信区间:1.3 - 8.7,P = 0.012)。合并感染调整后的GII归因分数为6.4%。
在一个低收入和中等收入国家纵向随访的成年人群中,诺如病毒是腹泻的常见病因。疫苗接种策略应考虑针对流行地区的成年人以及可能成为社区传播源的特殊人群。